Insider trades

Wendall Wierenga, Director of Cytokinetics CYTK, has filed 0 purchases and 8 sales on the open market. The latest trade was on 25/07/15.

Wendall Wierenga

Director
First filing
23/01/04
Trades
46 trades
Buys / sales
0 / 8
12-month net buying
No record
Last trade
25/07/15

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/04/2125/04/2120,000 sh$38.46$769,200−44.6%
Open-market sale10b5-1 plan24/12/1624/12/16742 sh$48.61$36,068.62−2.9%
Open-market sale10b5-1 plan24/11/2524/11/26742 sh$50.00$37,100−2.9%
Open-market sale10b5-1 plan24/10/2824/10/314,452 sh$52.25$232,617−15.3%
CYTK
Open-market sale10b5-1 plan23/12/2723/12/2710,000 sh2 trades$73.60avg.$736,000−34.9%
Open-market sale10b5-1 plan23/08/2123/08/216,020 sh$32.02$192,760.4−24.9%
Open-market sale23/02/0623/02/087,000 sh$45.00$315,000−35.8%